These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 9546996)

  • 21. Preclinical restenosis models and drug-eluting stents: still important, still much to learn.
    Schwartz RS; Chronos NA; Virmani R
    J Am Coll Cardiol; 2004 Oct; 44(7):1373-85. PubMed ID: 15464316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.
    Nakamura T; Morishita R; Asai T; Tsuboniwa N; Aoki M; Sakonjo H; Yamasaki K; Hashiya N; Kaneda Y; Ogihara T
    Gene Ther; 2002 Apr; 9(8):488-94. PubMed ID: 11948373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological observations late (greater than 30 days) after clinically successful coronary balloon angioplasty.
    Waller BF; Pinkerton CA; Orr CM; Slack JD; VanTassel JW; Peters T
    Circulation; 1991 Feb; 83(2 Suppl):I28-41. PubMed ID: 1991400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular radiation therapy to reduce coronary artery restenosis.
    Chougule PB
    Surg Oncol Clin N Am; 2000 Jul; 9(3):577-84, x. PubMed ID: 10853143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of nuclear NF-kappaB after coronary artery balloon injury can be inhibited by intracoronary beta-irradiation.
    Su CH; Hsieh BT; Leung SW; Wu CJ; Chiu SY; Lin CS
    Int J Radiat Biol; 2007 Oct; 83(10):707-16. PubMed ID: 17729165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug and instrumental therapeutic approaches for prevention of restenosis].
    Höfling B; Huehns TY; Gonschior P; Nikol S
    Z Kardiol; 1995; 84 Suppl 4():151-8. PubMed ID: 8585268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First experience with hybrid percutaneous transmyocardial laser revascularization and angioplasty in patients with lesions at high risk for restenosis: Results of a phase I feasibility study.
    Stone GW; St Goar FG; Taussig A; Power JA; Kosinski E; Shawl F
    Am Heart J; 2001 Oct; 142(4):679-83. PubMed ID: 11579359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Restenosis after percutaneous transluminal coronary angioplasty].
    Aschermann M
    Cas Lek Cesk; 1990 Apr; 129(17):513-5. PubMed ID: 2350767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The treatment of intra-stent restenosis. The current situation and future outlook].
    Gómez-Hospital JA; Cequier A; Fernández-Nofrerías E; Mauri J; García del Blanco B; Iráculis E; Jara F; Esplugas E
    Rev Esp Cardiol; 1999 Dec; 52(12):1130-8. PubMed ID: 10659658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis.
    Deiner C; Loddenkemper C; Rauch U; Rosenthal P; Pauschinger M; Schwimmbeck PL; Schultheiss HP; Pels K
    Cardiovasc Revasc Med; 2007; 8(2):94-8. PubMed ID: 17574167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infusion of an antialpha4 integrin antibody is associated with less neoadventitial formation after balloon injury of porcine coronary arteries.
    Labinaz M; Hoffert C; Pels K; Aggarwal S; Pepinsky RB; Leone D; Koteliansky V; Lobb RR; O'Brien ER
    Can J Cardiol; 2000 Feb; 16(2):187-96. PubMed ID: 10694589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [15 years of coronary angioplasty: focus on the different techniques].
    Dupouy P; Belarbi A; el Ghalid A; Aptecar E; Teiger E; Dubois-Rande JL
    Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):433-7. PubMed ID: 8669794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restenosis related to percutaneous coronary intervention has been solved?
    Kivelä A; Hartikainen J
    Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histopathological features of balloon coronary angioplasty].
    Basso C; Angelini A; Thiene G
    Cardiologia; 1994 Dec; 39(12 Suppl 1):47-51. PubMed ID: 7634313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathophysiology and burden of restenosis.
    Weintraub WS
    Am J Cardiol; 2007 Sep; 100(5A):3K-9K. PubMed ID: 17719351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting neointimal hyperplasia in stented arteries using time-dependant computational fluid dynamics: a review.
    Murphy J; Boyle F
    Comput Biol Med; 2010 Apr; 40(4):408-18. PubMed ID: 20211464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical, experimental and physiopathological aspects of restenosis after coronary angioplasty].
    Brami M; Côté G; Bonan R
    Arch Mal Coeur Vaiss; 1997 Mar; 90(3):385-91. PubMed ID: 9232077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery restenosis following transluminal coronary angioplasty.
    Bruneval P; Guermonprez JL; Perrier P; Carpentier A; Camilleri JP
    Arch Pathol Lab Med; 1986 Dec; 110(12):1186-7. PubMed ID: 2946273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing restenosis after angioplasty: a multistage approach.
    Zargham R
    Clin Sci (Lond); 2008 Feb; 114(4):257-64. PubMed ID: 18194134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing restenosis after coronary angioplasty.
    Popma JJ; Topol EJ
    Am J Med; 1990 Jan; 88(1N):16N-24N. PubMed ID: 2195881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.